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This article presents proteomics data referenced in [1] Using
proteomics-based evaluation of red blood cells (RBCs), we have
identiﬁed differentially abundant proteins associated with
Obstructive Sleep Apnea Syndrome (OSA). RBCs were collected from
peripheral blood of patients with moderate/severe OSA or snoring
at pre- (evening) and post-night (morning) polysomnography, so
that proteome variations between these time points could be
assessed. RBC cytoplasmic fraction depleted of hemoglobin, using
Hemovoid™ system, were analyzed by two-dimensional ﬂuores-
cence difference gel electrophoresis (2D-DIGE), the 2D image
software-based analyzed and relevant differentially abundant pro-
teins identiﬁed by mass spectrometry (MS). MS identiﬁed 31 protein
spots differentially abundant corresponding to 21 unique proteinsier Inc. This is an open access article under the CC BY license
/j.bbadis.2016.11.019
ómica, Departamento de Genética Humana, Instituto Nacional de Saúde Dr
e.pt (D. Penque).
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A. Feliciano et al. / Data in Brief 11 (2017) 103–110104possibly due to the existence of post-translational modiﬁcation
regulations. Functional analysis by bioinformatics tools indicated
that most proteins are associated with catalytic, oxidoreductase,
peroxidase, hydrolase, ATPase and anti-oxidant activity. At morning
a larger numbers of differential proteins including response to
chemical stimulus, oxidation reduction, regulation of catalytic
activity and response to stress were observed in OSA. The data
might support further research in OSA biomarker discovery and
validation.
& 2017 The Author. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaMolecular Medicine; Clinical Proteomicsype of data Figures, graphics and tables
ow data was
acquiredTwo-dimensional ﬂuorescence difference gel electrophoresis (2-D DIGE) -
based proteomics followed by image analysis with Progenesis SameSpots,
version 4.5 software (Nonlinear Dynamics, UK). Protein identiﬁcation by
mass spectrometry (MALDI/TOF/TOF). Pathway analysis by open source
DAVID software [2].ata format Filtered, analysed
xperimental
factorsRBC samples were hemoglobin (Hb) depleted, using Hemovoid™ system,
before analysis.xperimental
featuresSamples from OSA and Snorers (controls) patients biobank collected at
evening and morning time (i.e, before and after night polysomnographic
diagnosis) were enrolled.ata source
locationLisbon, Portugal,ata accessibility Data is with this articleValue of the data
 For the ﬁrst time (evening/morning) changes in OSA RBC proteome are shown probably induced by
nocturnal intermittent hypoxia and sleep disruption experienced by these patients.
 The provided data set may help to get new insights into RBC homeostasis which dysregulation can
be a source of oxidative-stress and/or inﬂammation causally linking OSA to cancer and cardiome-
tabolic disorders.
 These data could be used in further veriﬁcation/validation assays to selected candidates biomarker
of OSA severity and/or treatment response.1. Data
2-D gel reference image of OSA RBC cytoplasmic fraction depleted from hemoglobin was shown.
Graphics representing the identiﬁed variations for the different PRDX2 and Catalase proteoforms
between groups and conditions were highlighted as examples. The 31 proteins spots identiﬁed by
MALDI/TOF/TOF MS are displayed in detail in the Table. Fold-change histograms and pathway analysis
A. Feliciano et al. / Data in Brief 11 (2017) 103–110 105between patients’ groups and conditions were shown. Material and methods are provided in detail as
much as possible to be reproduced elsewhere.2. Experimental design, materials and methods
2.1. Sample collection and biochemical analysis
Patients with suspected OSA are hospitalized for an overnight polysomnography (PSG) study. For
the proteomics study [1], blood samples were collected into EDTA-coated polypropylene tubes
before and after PSG, i.e., between 8:00 pm and 09:30 pm (referred as ‘evening’) and between
7:30 am and 09:00 am (referred as ‘morning’). Samples were kept no longer than 4 h at 4 °C until
fractionation by centrifugation. The obtained RBC pellets were aliquoted and stored at 80 °C until
analysis.
2.2. RBC sample preparation
RBC pellet samples were lysated by incubation with (1:20) 5 mM phosphate buffer pH 7,4 con-
taining 1:100 cocktail of protease inhibitors (P8340, Sigma Aldrich) for 30 min at 4 °C followed
sonication 10 s/40 amplitude/pulse mode (Ultrasonic Processor, VibraCell, Sonics & Materials Inc,
USA). After centrifugation at 25.000 g for 30 min at 4 °C, the supernatant cytoplasm fractions were
recovered for further hemoglobin (Hb) depletion using Hemovoid depletion columns (Biotech Sup-
port Group, Monmouth JCT, USA), according to the manufacture's protocol. The obtained Hb depleted
fractions were concentrated and buffer-exchanged with 25 mM NH4HCO3 pH 8.4 by centrifugal ﬁl-
tration using 3-kD Molecular Weight Cut-Offs (MWCO) (Amicon Ultra 4, Millipore) spin con-
centrators. The protein concentration was determined by a colorimetric assay (Pierce BCA Protein
Assay Kit, Thermo Fisher) according to the manufacturer's protocol. The efﬁciency of Hb-depletion
was conﬁrmed by analysing samples (10 μg/lane) on coomassie stained 4–12% SDS-PAGE mini gels
(NuPAGE Novex Bis Tris, Invitrogen, USA) (data not shown). Samples were stored at 80 °C until
further analysis.
2.3. 2D-DIGE
Analysis of Hb-depleted pooled samples (n¼3/group) from the four study groups was based on a
2D-DIGE approach, using the CyDye DIGE ﬂuor minimal dyes Cy3 and Cy5 from GE Healthcare.
Brieﬂy, 50 μg of each pooled samples (in duplicate) were lyophilized and resuspended in 6.25 ul of
lysis buffer (7 M urea, 2 M thiourea, 2% (w/v) 3-[(3-cholamidopropyl) dimethylammonio]- 1-
propanesulfonate (CHAPS) and incubated with 400 pmol Cy5 solution for 30 min at 4 °C in the
dark. The labelling reaction was stopped by adding 1 μL of 10 mM lysine and the samples were
incubated for another 10 min. A sample of each pool was pooled together and labelled with Cy3 as
above described to comprise the internal standard (IS) for each gel. Each Cy5 labelled sample was
combined with an equal amount of Cy3 labelled IS sample (50 μg:50 μg) and mixed with lysis buffer
for with a trace of bromophenol blue to 140 μl ﬁnal volume. To ensure an optimal focusing of the
proteins, an ampholyte solution for pH 3–10 NL (Serva, Heidelberg, Germany) was added in a
concentration of 1% and the samples were loaded to 24-cm IPG strips with a pH gradient of 3-10NL
(GE Healthcare) previously rehydrated for 20 h at RT with 310 μl of lysis buffer. IEF was performed in
an Ettan IPGphor 3 (GE Healthcare) in ceramic manifold with cup loading of the sample, and
focused as follows: step and hold 100 V for 5 h, gradient 300 V for 2 h, gradient 500 V for 1 h,
gradient 1000 V for 2 h, gradient 2000 V for 1 h, gradient 6000 V for 3 h and 8000 V for 2 h, fol-
lowed by step and hold at 8000 V for 8 h. The maximum current per strip was set to 50 μA. Prior to
2nd dimension stripes were equilibrated once with 8 mL of SDS equilibration buffer (6 M urea,
75 mM Tris–HCl pH 8.8, 29.3% glycerol (87%), 2% SDS and a trace of bromphenol blue) including 1%
Fig. 1. 2DIGE reference map of Hb-depleted RBC from OSA and Snorers patients collected at evening or morning day time. (A) The
31 protein spots exhibiting signiﬁcant differences in abundance (fold change Z 1.2; Anova po0.05) between OSA and Snorers at
evening or morning times that were identiﬁed by MS, corresponding to 21 unique proteins in consequence of post-translational
modiﬁcation (PTM) regulations are indicated with circles on the 2D gel image. The identity of these proteins is fully described in the
Table 1. As an example, catalase proteoforms (B) and peroxiredoxin-2 proteoforms (C) are described in more detail. (B) About
8 proteoforms for catalase were identiﬁed. The most acidic ones (spot 4–9 or n°1–6) probably resulting from phosphorylation [4]
were shown signiﬁcantly decreased in OSA morning samples. (C) At least three peroxiredoxin-2 protoforms were identiﬁed. The
acidic monomeric forms (spot 18 or n° 1) and dimeric forms (spot 19 or n°2) reported as oxi/overoxidized forms of peroxiredoxin-2
[5] were signﬁcantly increased in OSA RBC at morning evening daytime, respectively.
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Fig. 2. Fold-change histogram and pathway analysis of RBC proteins/proteoforms with differential abundance in OSA versus
Snorers at morning or evening and Morning versus Evening in Snorers or OSA (read from top to down). Proteins/proteoforms
with signiﬁcant differential abundance from each comparable group/condition were plotted on the histograms, which the log
volume ratio of (7) 1.0 represents a 10-fold increase/decrease changes. The most representative biological processes retrieved
from DAVID v6.7 [6] are shown on the bottom of each respective histograms.
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Table 1
Annotation of differential RBC cytosolic proteins between OSA and Snorers at Evening and Morning.
Spot Protein name Acession ID MW/pI Mascot
Score
Sequence
Coverage (%)
Anova
(p)
Fold (Anova
po0.05)
1 Actin ACTB_HUMAN 42052/
5.29
73 20 0.016 1.4
2 Actin ACTB_HUMAN 42052/
5.29
26 2 0.042 1.2
3 Arginine and glutamate-rich pro-
tein 1
ARGL1_HUMAN 33197/
10.35
60 11 0.036 1.5
4 Catalase CATA_HUMAN 59719/
6.90
663 25 0.009 1.3
5 Catalase CATA_HUMAN 59719/
6.90
253 7 0.002 1.3
6 Catalase CATA_HUMAN 59719/
6.90
896 34 3.8E-
06
1.4
7 Catalase CATA_HUMAN 59719/
6.90
730 31 4.9E-
04
1.3
8 Catalase CATA_HUMAN 59719/
6.90
797 29 0.001 1.3
9 Catalase CATA_HUMAN 59719/
6.90
397 21 0.012 1.4
10 Fructose-bisphosphate aldolase A ALDOA_HUMAN 39851/
8.30
76 24 0.034 1.8
11 Glutamate–cysteine ligase reg-
ulatory subunit
GSH0_HUMAN 30708/
5.69
235 26 0.020 1.2
12 Heat shock 70 kDa protein 1A/1B HSP71_HUMAN 70294/
5.48
201 29 0.007 1.8
13 Heat shock cognate 71 kDa protein HSP7C_HUMAN 70854/
5.37
52 2 0.019 1.2
14 Heat shock cognate 71 kDa protein HSP7C_HUMAN 70854/
5.37
380 23 3.8E-
04
2.1
15 Hemoglobin subunit beta HBB_HUMAN 16102/
6.75
142 63 0.005 1.3
16 Hemoglobin subunit beta HBB_HUMAN 16102/
6.75
61 8 0.024 1.4
17 L-lactate dehydrogenase B chain LDHB_HUMAN 36615/
5.72
412 32 0.003 1.3
18 Peroxiredoxin-2 PRDX2_HUMAN 22049/
5.66
857 64 0.031 1.2
19 Peroxiredoxin-2 PRDX2_HUMAN 22049/
5.66
85 29 0.004 1.2
20 Probable global transcription
activator SNF2L2
SMCA2_HUMAN 181166/
6.76
34 4 0.019 1.3
21 26 S protease regulatory subunit
6 A
PRS6A_HUMAN 49458/
5.13
117 30 0.006 1.4
22 Proteasome subunit alpha type-1 PSA1_HUMAN 29822/
6.15
166 39 0.001 1.2
23 14-3-3 protein epsilon 1433E_HUMAN 29155/
4.63
96 4 0.007 1.4
24 Purine nucleoside phosphorylase PNPH_HUMAN 32097/
6.45
542 40 0.019 1.2
25 Putative inactive group IIC secre-
tory phospholipase A2
PA2GC_HUMAN 16833/
8.84
13 14 0.016 1.2
26 Putative uncharacterized protein
FLJ45999
YL004_HUMAN 18957/
10.14
32 10 0.012 1.2
27 Putative zinc ﬁnger protein 861 ZN861_HUMAN 11989/
8.91
30 17 0.037 1.2
28 RuvB-like 1 RUVB1_HUMAN 50538/
6.02
64 19 4.7E-
04
1.3
29 Serine/threonine-protein phos-
phatase 2 A activator
PTPA_HUMAN 40641/
5.63
246 17 1.1E-
04
1.3
30 Uroporphyrinogen decarboxylase DCUP_HUMAN 40761/
5.77
32 2 0.007 1.3
31 Uroporphyrinogen decarboxylase DCUP_HUMAN 40761/
5.77
134 8 0.010 1.2
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of cysteine residues with equilibration buffer containing 4% of iodacetamide (15 min, RT).
Second-dimension separation was performed using Ettan DALT six electrophoresis system
(GE Healthcare) using 12.5% SDS-PAGE running overnight with a power of 1 W per gel and at a
constant temperature of 15 °C. A preparative 2D-gel stained with coomassie blue, containing equal
amount of each non-labeled pooled samples mixed with 50 μg of IS labeled sample, in a total of
700 μg of proteins, was performed for further spot cutoff for mass spectrometry (MS) protein iden-
tiﬁcation. Introducing some labeled sample into preparative gel facilitates gel match with analytical
gels for spot location and picking for MS analysis.
2.4. 2D-DIGE image analysis
Each gel was scanned at 100 μm resolution using an Amersham Biosciences Typhoon 8400 vari-
able imager, resulting in two images, one for the IS and one for the sample. To improve the signal
collection capabilities of the instrument and avoid image saturation, a prescan was performed to
check and adjust the photomultiplier tube (PMT) voltages of the different channels that were set to
values between 500 and 550 V.
Spot detection, gel matching, and statistical analysis were performed with Progenesis SameSpots,
version 4.5 (Nonlinear Dynamics, UK). Abundance values of matched spots across all gel images,
expressed as normalized volume, were compared between groups, so that each spot could be
assigned a score of relative signiﬁcant difference, in terms of p value (o0.05). Relative content
alteration of each spot across the study groups was expressed by fold change values, which were
calculated by the ratio of the mean normalized volumes of a certain spot in each condition. Spots
decreasing their abundance were represented by negative fold values, calculated as the inverse of the
previous ratio multiplied by 1 (Fig. 1).
2.5. Protein identiﬁcation
After in-gel digestion of protein spots collected from the preparative gel, proteins were
identiﬁed by MS. The protein spot picking was performed manually. In-gel digestion was per-
formed as described before [2]. Tryptic peptides, prepared in 50% (v/v) ACN and 0.1% (v/v) tri-
ﬂuoroacetic acid (TFA), were directly deposited on a 192-well matrix-assisted laser desorption/
ionization (MALDI) plate with 5 mg/ml α-cyano-4-hydroxycinnamic acid (α- CHCA, 1:1), pre-
pared in 0.1% TFA/60% ACN (v/v) and allowed to co-crystallize at RT. Peptides were analyzed on
an Applied Biosystems 4700 MALDI Proteomics Analyzer (with time-of-ﬂight/time-of-ﬂight
(TOF/TOF) ion optics exactly as described before [2,3]. The identiﬁed proteins are displayed in
the Table.
2.6. Protein annotation and classiﬁcation
Protein annotation properties were acquired using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.7 [6]. This open-source tool retrieves a set of biological
and functional information such as GO terms, subcellular location, molecular function and
association with biological process and/or disease with p-values of over-representation r0.05
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